US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

ARS PHARMACEUTICALS INC

17.62

-0.2626-1.47%

Volume:671.85K

Turnover:11.91M

Market Cap:1.73B

PE:-109.57

High:17.91

Open:17.75

Low:17.51

Close:17.88

Loading ...

Overview Company News Filings

Calendar of U.S. Earnings Expected in the Week Ahead

Calendar of U.S. Earnings Expected in the Week Ahead

ARS Pharmaceuticals Initiated at Sector Outperform by Scotiabank

Exploring High Growth Tech Stocks in the US Market

Simply Wall St.

ARS Pharmaceuticals initiated with an Outperform at Scotiabank

BUZZ-U.S. STOCKS ON THE MOVE-CoreCivic, Teladoc, Dynavax

BUZZ-U.S. STOCKS ON THE MOVE-Scienture, ARS Pharma, BrightSpring Health

BUZZ-ARS Pharma rises on expanded US approval for allergic reaction nasal spray

Analysts Offer Insights on Healthcare Companies: ARS Pharmaceuticals (SPRY) and Corbus Pharmaceuticals (CRBP)

ARS Pharmaceuticals Says US FDA Approves Lower Dosage of Neffy Nasal Spray

MT Newswires Live

BRIEF-ARS Pharmaceuticals Announces FDA Approval of neffy® 1 mg (epinephrine nasal spray) for Type I Allergic Reactions

ARS Pharmaceuticals announces FDA approval for neffy 1 mg

US FDA expands use of ARS Pharma's allergic reaction nasal spray in 15-30 kg patients

US FDA expands use of allergic reaction nasal spray in people between 15-30 kilograms

3 Growth Companies With High Insider Ownership Growing Earnings Up To 61%

Simply Wall St.

ARS Pharmaceuticals Announces Conference Call and Webcast for its Fourth Quarter and Full Year 2024 Financial Results and Participation at Upcoming Conferences

ARS Pharmaceuticals (SPRY) Receives a Buy from William Blair

Oppenheimer Initiates ARS Pharmaceuticals at Outperform

MT Newswires Live

VR Resources Provides Exploration Update on Silverback and Empire Projects in Ontario

ARS Pharmaceuticals to Participate in the Oppenheimer 35th Annual Healthcare Conference

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SPRY/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SPRY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SPRY\",,,,,undefined,":{"symbol":"SPRY","market":"US","secType":"STK","nameCN":"ARS PHARMACEUTICALS INC","latestPrice":17.6174,"timestamp":1753988974673,"preClose":17.88,"halted":0,"volume":671848,"delay":0,"floatShares":53634396,"shares":98213561,"eps":-0.160792,"marketStatus":"Trading","change":-0.2626,"latestTime":"07-31 15:09:34 EDT","open":17.75,"high":17.91,"low":17.51,"amount":11909391.295664,"amplitude":0.022371,"askPrice":17.62,"askSize":161,"bidPrice":17.6,"bidSize":208,"shortable":3,"etf":0,"ttmEps":-0.160792,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1753992000000},"marketStatusCode":2,"adr":0,"listingDate":1607058000000,"exchange":"NASDAQ","adjPreClose":17.88,"preHourTrading":{"tag":"盘前","latestPrice":17.74,"preClose":17.88,"latestTime":"09:29 EDT","volume":2190,"amount":38908.76639999999,"timestamp":1753968599999},"postHourTrading":{"tag":"盘后","latestPrice":17.88,"preClose":17.88,"latestTime":"19:04 EDT","volume":11561,"amount":206731.32,"timestamp":1753916647565},"volumeRatio":0.486736,"impliedVol":0.6495,"impliedVolPercentile":0.304},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SPRY\",,,,,undefined,":{"symbol":"SPRY","floatShares":53634396,"roa":"-6.10%","roe":"-6.91%","lyrEps":0.082507,"volumeRatio":0.486736,"shares":98213561,"dividePrice":0,"high":17.91,"amplitude":0.022371,"preClose":17.88,"low":17.51,"week52Low":8.9055,"pbRate":"7.56","psRate":"17.82","week52High":18.9,"institutionHeld":0,"latestPrice":17.6174,"committee":0.127371,"eps":-0.160792,"divideRate":0,"volume":671848,"delay":0,"ttmEps":-0.160792,"open":17.75,"prevYearClose":10.55,"prevWeekClose":17.87,"prevMonthClose":17.45,"prevQuarterClose":17.45,"fiveDayClose":17.92,"twentyDayClose":16.75,"sixtyDayClose":14.26},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SPRY\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2520889517","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2520889517","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520889517?lang=en_us&edition=fundamental","pubTime":"2025-03-17 18:00","pubTimestamp":1742205600,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Bitcoin Depot Inc.                               4Q       .02   8:05 AM. ·IHS Hldg Ltd.                                    4Q       .01   6:00 AM","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RBOT","STTK","NRXP","CELC","OPTN","HYPR","SCPH","CMC","CBUS","KOPN","INO","DMAC","ANRO","PHUN","IMTX","FLUX","CNTX","ASO","LPRO","LEN.B","BLTE","OSS","PL","RWAY","SPRY","NOA","BCAB","AUTL","BTM","SIG","ABSI","RANI","CAL","KLC","SGMO","DRI","AEVA","FIVE","LAR","LQDA","SAIC","DERM","GLUE","MSIF","STNE","LVTX","LXEO","OABI"],"gpt_icon":1},{"id":"2519876572","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2519876572","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519876572?lang=en_us&edition=fundamental","pubTime":"2025-03-14 18:00","pubTimestamp":1741946400,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Bitcoin Depot Inc.                               4Q       .02   8:05 AM. ·IHS Hldg Ltd.                                    4Q       .01   6:00 AM","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXEO","RANI","AMPX","HTHT","NKTX","PRSO","GANX","LPRO","IDN","HROW","LE","NRXP","GOGO","AUTL","INKT","OSS","LQDA","PL","DTI","CNTX","SPRY","MBRX","HYPR","RLYB","ANRO","INSE","ACN","LVTX","MRC","KOPN","ERAS","LAR","FDX","CAL","IFRX","CAPR","FDS","DRI","STNE","JILL","DTIL","MGNX","TME","AEVA","GIS","ABSI","TYRA"],"gpt_icon":1},{"id":"2517464872","title":"ARS Pharmaceuticals Initiated at Sector Outperform by Scotiabank","url":"https://stock-news.laohu8.com/highlight/detail?id=2517464872","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517464872?lang=en_us&edition=fundamental","pubTime":"2025-03-08 06:27","pubTimestamp":1741386420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SPRY/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 07, 2025 17:27 ET (22:27 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRY"],"gpt_icon":0},{"id":"2517914455","title":"Exploring High Growth Tech Stocks in the US Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2517914455","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517914455?lang=en_us&edition=fundamental","pubTime":"2025-03-08 01:08","pubTimestamp":1741367302,"startTime":"0","endTime":"0","summary":"Over the last 7 days, the United States market has dropped 2.7%, yet in the longer term, it has risen by 11% over the past year with earnings forecasted to grow by 14% annually. In this context of fluctuating short-term performance and promising long-term growth prospects, identifying high growth tech stocks involves evaluating companies that demonstrate strong innovation potential and resilience in adapting to changing market conditions.Top 10 High Growth Tech Companies In The United States. Click here to see the full list of 235 stocks from our US High Growth Tech and AI Stocks screener.Examine ARS Pharmaceuticals' past performance report to understand how it has performed in the past.Overview: UroGen Pharma Ltd. is a biotechnology company focused on developing and commercializing treatments for urothelial and specialty cancers, with a market ca","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exploring-high-growth-tech-stocks-170822327.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["URGN","SPRY","PEGA","BK4139"],"gpt_icon":0},{"id":"2517481881","title":"ARS Pharmaceuticals initiated with an Outperform at Scotiabank","url":"https://stock-news.laohu8.com/highlight/detail?id=2517481881","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517481881?lang=en_us&edition=fundamental","pubTime":"2025-03-07 19:50","pubTimestamp":1741348243,"startTime":"0","endTime":"0","summary":"Scotiabank analyst Louise Chen initiated coverage of ARS Pharmaceuticals (SPRY) with an Outperform rating and $30 price target The firm says it is ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ars-pharmaceuticals-initiated-with-an-outperform-at-scotiabank?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ars-pharmaceuticals-initiated-with-an-outperform-at-scotiabank?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"2517216456","title":"BUZZ-U.S. STOCKS ON THE MOVE-CoreCivic, Teladoc, Dynavax","url":"https://stock-news.laohu8.com/highlight/detail?id=2517216456","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517216456?lang=en_us&edition=fundamental","pubTime":"2025-03-06 23:41","pubTimestamp":1741275681,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-CoreCivic, Teladoc, DynavaxEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https:","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nL3N3PP1CU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4543","BAC","CZR","TDOC","KBH","DVAX","NEM","LULU","BTSG","BK4560","FAST","LU2023250843.SGD","SPRY","CPB","IE00BJTD4V19.USD","LEN","VG","VSCO","IBRX","LU0149725797.USD","FCX","HUT","LU1267930573.SGD","LU1223082196.USD","SCNX","LU0820561818.USD","IE00BKVL7J92.USD","MOS","LU2552382215.SGD","CXW","HTGC","LU1496350171.SGD","LU1699723380.USD","MRVL","MDB","DHI","BURL","PHM","IE00BJTD4N35.SGD","ALGM","ZS","LU0648001328.SGD","LU1366192091.USD","KR"],"gpt_icon":1},{"id":"2517168920","title":"BUZZ-U.S. STOCKS ON THE MOVE-Scienture, ARS Pharma, BrightSpring Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2517168920","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517168920?lang=en_us&edition=fundamental","pubTime":"2025-03-06 22:09","pubTimestamp":1741270157,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Scienture, ARS Pharma, BrightSpring HealthEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call new","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"e5c43d65b893d390fb338910195c4df7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nL6N3PP0KV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BTSG","LU2237438978.USD","IE00B64PRP62.GBP","NEM","LU2028103732.USD","LU0082616367.USD","LU2125909916.SGD","LU2237443978.SGD","MDB","LU1989764748.USD","LU2360107168.USD","IE00BZ1G4Q59.USD","LU1914381329.SGD","LU2750360997.AUD","LU2498475776.HKD","LU2471134523.USD","BK4560","LU2430703251.USD","LU2089284900.SGD","BURL","FCX","VSCO","LU0708994859.HKD","LU1883839398.USD","LU2756315318.SGD","LU1732800096.USD","IE00B7SZLL34.SGD","ALGM","LU1506573853.SGD","LU0048584097.USD","BAC","LU0320765489.SGD","LU1244550577.SGD","IBRX","IE00BMPRXN33.USD","LU0971096721.USD","BK4604","IE00BHPRN162.USD","LU0648001328.SGD","SPRY","LU0788109121.HKD","SCNX","IE00BBT3K403.USD","LU0719512351.SGD","KKR","ZS","LU0330918003.SGD","CPB"],"gpt_icon":1},{"id":"2517157459","title":"BUZZ-ARS Pharma rises on expanded US approval for allergic reaction nasal spray","url":"https://stock-news.laohu8.com/highlight/detail?id=2517157459","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517157459?lang=en_us&edition=fundamental","pubTime":"2025-03-06 21:37","pubTimestamp":1741268277,"startTime":"0","endTime":"0","summary":"BUZZ-ARS Pharma rises on expanded US approval for allergic reaction nasal spray** Shares of drug developer ARS Pharmaceuticals SPRY.O rise 2.6% to $11.15 premarket** Co said late on Wednesday the U.S. FDA approved the expanded use of nasal spray for severe allergic reactions in patients who weigh between 15 kg and 30 kg** The spray, sold under the brand name neffy, will be dosed at 1 mg for the new patient population** Neffy is designed to be given at the first sign of a severe allergic reaction, and has been previously approved for people above 30 kg at dose of 2 mg** SPRY has risen 21.5% in the past 12 months  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nL3N3PP0VF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"2517158621","title":"Analysts Offer Insights on Healthcare Companies: ARS Pharmaceuticals (SPRY) and Corbus Pharmaceuticals (CRBP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2517158621","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517158621?lang=en_us&edition=fundamental","pubTime":"2025-03-06 19:00","pubTimestamp":1741258816,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on ARS Pharmaceuticals (SPRY – Research Report) and Cor...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ars-pharmaceuticals-spry-and-corbus-pharmaceuticals-crbp?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ars-pharmaceuticals-spry-and-corbus-pharmaceuticals-crbp?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","CRBP","SPRY","HCSG","BK4139"],"gpt_icon":0},{"id":"2517209939","title":"ARS Pharmaceuticals Says US FDA Approves Lower Dosage of Neffy Nasal Spray","url":"https://stock-news.laohu8.com/highlight/detail?id=2517209939","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517209939?lang=en_us&edition=fundamental","pubTime":"2025-03-06 06:37","pubTimestamp":1741214262,"startTime":"0","endTime":"0","summary":"ARS Pharmaceuticals  said the US Food and Drug Administration approved a lower dosage of neffy for allergic emergencies, including anaphylaxis.The regulator approved a 1 milligram version of the nasal spray for children 4 years and up, the company said Wednesday in a statement.A 2 mg version of neffy, an epinephrine nasal spray, was approved in the US in 2024.ARS shares rose 5.1% in after-hours trading.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","SPRY"],"gpt_icon":0},{"id":"2517927311","title":"BRIEF-ARS Pharmaceuticals Announces FDA Approval of neffy® 1 mg (epinephrine nasal spray) for Type I Allergic Reactions","url":"https://stock-news.laohu8.com/highlight/detail?id=2517927311","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517927311?lang=en_us&edition=fundamental","pubTime":"2025-03-06 06:09","pubTimestamp":1741212595,"startTime":"0","endTime":"0","summary":"BRIEF-ARS Pharmaceuticals Announces FDA Approval of neffy 1 mg (epinephrine nasal spray) for Type I Allergic ReactionsMarch 5 (Reuters) - ARS Pharmaceuticals Inc SPRY.O:ARS PHARMACEUTICALS ANNOUNCES F","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nTUA4R29QJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"2517922253","title":"ARS Pharmaceuticals announces FDA approval for neffy 1 mg","url":"https://stock-news.laohu8.com/highlight/detail?id=2517922253","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517922253?lang=en_us&edition=fundamental","pubTime":"2025-03-06 05:46","pubTimestamp":1741211185,"startTime":"0","endTime":"0","summary":"ARS Pharmaceuticals (SPRY) announced that the FDA has approved neffy 1 mg for the treatment of Type I Allergic Reactions, including anaphylaxis, in...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ars-pharmaceuticals-announces-fda-approval-for-neffy-1-mg?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ars-pharmaceuticals-announces-fda-approval-for-neffy-1-mg?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","SPRY"],"gpt_icon":0},{"id":"2517212219","title":"US FDA expands use of ARS Pharma's allergic reaction nasal spray in 15-30 kg patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2517212219","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517212219?lang=en_us&edition=fundamental","pubTime":"2025-03-06 05:21","pubTimestamp":1741209694,"startTime":"0","endTime":"0","summary":"UPDATE 2-US FDA expands use of ARS Pharma's allergic reaction nasal spray in 15-30 kg patientsAdds analyst comments in paragraphs 7-9; CEO comments in paragraphs 11 & 12 and details throughoutBy Chris","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nL3N3PO1TS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","SPRY","BK4007","BK4588","LU1839511570.USD","VTRS","BK4139","LU2087621335.USD","BK4585"],"gpt_icon":0},{"id":"2517921969","title":"US FDA expands use of allergic reaction nasal spray in people between 15-30 kilograms","url":"https://stock-news.laohu8.com/highlight/detail?id=2517921969","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517921969?lang=en_us&edition=fundamental","pubTime":"2025-03-06 05:14","pubTimestamp":1741209258,"startTime":"0","endTime":"0","summary":"US FDA expands use of allergic reaction nasal spray in people between 15-30 kilogramsMarch 5  - The U.S. Food and Drug Administration approved the expanded use of ARS Pharmaceuticals' SPRY.O nasal spray for severe allergic reactions in patients who weigh between 15 to 30 kilograms, the company said on Wednesday.   ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nL3N3PO1TM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4583","VTRS","BK4007","LU2087621335.USD","BK4588","SPRY","LU1839511570.USD","BK4139"],"gpt_icon":0},{"id":"2517294278","title":"3 Growth Companies With High Insider Ownership Growing Earnings Up To 61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517294278","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517294278?lang=en_us&edition=fundamental","pubTime":"2025-03-06 01:05","pubTimestamp":1741194344,"startTime":"0","endTime":"0","summary":"In the current U.S. market environment, investors are navigating mixed signals as they await news on tariffs and digest fresh economic data, with major indices reflecting a cautious sentiment amid broader economic concerns. In such times, companies that showcase high insider ownership coupled with strong earnings growth can be particularly appealing, as insider stakes often indicate confidence in the company's future prospects.Top 10 Growth Companies With High Insider Ownership In The United States. Click here to see the full list of 202 stocks from our Fast Growing US Companies With High Insider Ownership screener.OPAL Fuels is experiencing strategic growth, highlighted by joint ventures to develop landfill RNG projects and the acquisition of a fueling station in California. The company expects earnings growth of 29.24% annually, surpassing the US market average. However, profit margins have decreased from 8.7% to 1.6%, and interest payments are not well covered by earnings. Recent ex","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-growth-companies-high-insider-170544341.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TIGR","SPRY","OPAL"],"gpt_icon":1},{"id":"2516366964","title":"ARS Pharmaceuticals Announces Conference Call and Webcast for its Fourth Quarter and Full Year 2024 Financial Results and Participation at Upcoming Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2516366964","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516366964?lang=en_us&edition=fundamental","pubTime":"2025-03-04 05:35","pubTimestamp":1741037700,"startTime":"0","endTime":"0","summary":"Company to Host Conference Call on March 20 at 8:30 a.m. ET. In addition, ARS Pharma Management will be participating in several upcoming investor conferences:. Leerink Partners Global Healthcare Conference: fireside chat on March 10, 2025. 37thAnnual Roth Conference: investor meetings on March 16-18, 2025. To access the webcast and slides, please visit the Events & Presentations page in the Investors & Media section of the Company’s website. A replay of the webcast will be available for 30 days following the event.About ARS Pharmaceuticals, Inc. ARS Pharmaceuticals is a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect patients from allergic reactions that could lead to anaphylaxis. The company is commercializing neffy 2 mg  , an epinephrine nasal spray indicated in the U.S. for emergency treatment of Type I allergic reactions, including anaphylaxis, in adult and pediatric patients who weigh 30 kg or greater, and in the EU for em","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ars-pharmaceuticals-announces-conference-call-213500429.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"2516681877","title":"ARS Pharmaceuticals (SPRY) Receives a Buy from William Blair","url":"https://stock-news.laohu8.com/highlight/detail?id=2516681877","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516681877?lang=en_us&edition=fundamental","pubTime":"2025-03-03 18:26","pubTimestamp":1740997562,"startTime":"0","endTime":"0","summary":"In a report released today, Lachlan Hanbury Brown from William Blair reiterated a Buy rating on ARS Pharmaceuticals (SPRY – Research Report). The c...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ars-pharmaceuticals-spry-receives-a-buy-from-william-blair?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ars-pharmaceuticals-spry-receives-a-buy-from-william-blair?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"2510856507","title":"Oppenheimer Initiates ARS Pharmaceuticals at Outperform","url":"https://stock-news.laohu8.com/highlight/detail?id=2510856507","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510856507?lang=en_us&edition=fundamental","pubTime":"2025-02-10 20:12","pubTimestamp":1739189528,"startTime":"0","endTime":"0","summary":"ARS Pharmaceuticals (SPRY) has an average rating of buy and mean price target of $32.50, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OPY","SPRY"],"gpt_icon":0},{"id":"2509277418","title":"VR Resources Provides Exploration Update on Silverback and Empire Projects in Ontario","url":"https://stock-news.laohu8.com/highlight/detail?id=2509277418","media":"MT Newswires","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509277418?lang=en_us&edition=fundamental","pubTime":"2025-02-06 22:51","pubTimestamp":1738853492,"startTime":"0","endTime":"0","summary":"VR Resources  on Thursday said that two holes are complete and a third is underway at the Silverback project in northwestern Ontario.The company said data from the down-hole EM survey at the Westwood target at the Empire Project has also arrived. VRR expects all remaining geochemical data from the December drill program next week.\"The geological observations so far at Silverback are consistent with our exploration model, using state-of-the-art 3D DCIP data to identify sulfide anchored to a major structure that is evident in our magnetic data,\" said VR Resources Chief Executive Justin Daley. \"The presence of trace molybdenite in drill core, along with disseminated pyrite in silicified porphyry with stockwork veining is particularly exciting as it reminds us of known intrusion-related gold systems in the Archean Superior craton elsewhere in Ontario.\". The final geochemical data from Westwood's drill program has been delayed due to staffing challenges at the laboratories in both Thunder B","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vr-resources-provides-exploration-silverback-145132042.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","SPRY","VR"],"gpt_icon":0},{"id":"2509831982","title":"ARS Pharmaceuticals to Participate in the Oppenheimer 35th Annual Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2509831982","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509831982?lang=en_us&edition=fundamental","pubTime":"2025-02-05 21:00","pubTimestamp":1738760400,"startTime":"0","endTime":"0","summary":"SAN DIEGO, Feb. 05, 2025  -- ARS Pharmaceuticals, Inc. , a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions that could lead to anaphylaxis, today announced its participation in the Oppenheimer 35th Annual Healthcare Conference being held virtually.Richard Lowenthal, Co-Founder, President and CEO of ARS Pharma and Eric Karas, Chief Commercial Officer of ARS Pharma will participate in a fireside chat on Wednesday, February 12, 2025, at 2:40 p.m. ET. Company management will also participate in one-on-one meetings with investors.A live webcast of the fireside chat will be available here, and in the Investors & Media section of the Company’s website. A replay of the webcast will be archived on the Company’s website for 90 days.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ars-pharmaceuticals-participate-oppenheimer-35th-130000326.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SPRY","OPY","BK4139","HCSG","BK4137","BK4127"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":4,"totalSize":83,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SPRY\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-14","symbol":"SPRY","fiscalQuarterEnding":"2025/03","expectedEps":-0.35,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"pre","actualEps":-0.35},{"market":"US","date":"2025-03-20","symbol":"SPRY","fiscalQuarterEnding":"2024/12","expectedEps":-0.04,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742443200000,"reportTimeType":"pre","actualEps":0.52},{"market":"US","date":"2025-01-13","symbol":"SPRY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1736744400000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2024-11-13","symbol":"SPRY","fiscalQuarterEnding":"2024/09","expectedEps":-0.18,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"pre","actualEps":-0.2},{"market":"US","date":"2024-08-06","symbol":"SPRY","fiscalQuarterEnding":"2024/06","expectedEps":-0.12,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1722916800000,"reportTimeType":"post","actualEps":-0.13}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SPRY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SPRY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6667,"buy":0.3333,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6667,"analysts":6,"updateTime":1741320000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SPRY\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SPRY","date":"2025-07-29","current":-115.157754,"percent":0,"low":-115.157754,"twenty":-30.612951,"median":-18.201631,"eighty":-12.003593,"high":184.020638,"avg":-15.698117,"sd":50.868757,"marketCap":1802218844},"quantilePoints":[{"date":"2022-11-11","current":-28.534516,"twenty":-28.349227,"median":-28.071294,"eighty":-27.904534,"marketCap":577624216},{"date":"2022-11-18","current":-27.515427,"twenty":-28.349227,"median":-28.00181,"eighty":-27.867476,"marketCap":556994780},{"date":"2022-11-25","current":-28.627161,"twenty":-29.164499,"median":-28.302905,"eighty":-27.978649,"marketCap":579499619},{"date":"2022-12-02","current":-32.332942,"twenty":-29.813011,"median":-28.534516,"eighty":-27.978649,"marketCap":654515751},{"date":"2022-12-09","current":-33.352032,"twenty":-32.629404,"median":-28.951417,"eighty":-27.987913,"marketCap":675145188},{"date":"2022-12-16","current":-37.428392,"twenty":-33.870842,"median":-29.970507,"eighty":-28.034236,"marketCap":757662933},{"date":"2022-12-23","current":-37.428392,"twenty":-36.761351,"median":-31.221208,"eighty":-28.136145,"marketCap":757662933},{"date":"2022-12-30","current":-39.512894,"twenty":-37.428392,"median":-32.842487,"eighty":-28.39555,"marketCap":799859507},{"date":"2023-01-06","current":-33.490999,"twenty":-37.558094,"median":-33.236227,"eighty":-28.506723,"marketCap":677958292},{"date":"2023-01-13","current":-34.510089,"twenty":-37.428392,"median":-33.352032,"eighty":-28.608632,"marketCap":698587729},{"date":"2023-01-20","current":-24.704541,"twenty":-37.261632,"median":-32.981454,"eighty":-28.089644,"marketCap":627322403},{"date":"2023-01-27","current":-23.338221,"twenty":-36.955904,"median":-32.518231,"eighty":-27.978649,"marketCap":592627442},{"date":"2023-02-03","current":-26.292426,"twenty":-36.631648,"median":-30.109473,"eighty":-26.233342,"marketCap":667643574},{"date":"2023-02-10","current":-28.323442,"twenty":-36.44636,"median":-29.576768,"eighty":-26.233342,"marketCap":719217165},{"date":"2023-02-17","current":-31.868488,"twenty":-36.103575,"median":-29.970507,"eighty":-27.026227,"marketCap":809236523},{"date":"2023-02-24","current":-30.539096,"twenty":-35.51065,"median":-30.109473,"eighty":-27.543213,"marketCap":775479264},{"date":"2023-03-03","current":-33.641011,"twenty":-34.760229,"median":-30.612951,"eighty":-27.668279,"marketCap":854246203},{"date":"2023-03-10","current":-29.025066,"twenty":-34.306271,"median":-30.649879,"eighty":-27.867476,"marketCap":737033496},{"date":"2023-03-17","current":-31.056082,"twenty":-33.963486,"median":-30.631415,"eighty":-27.978649,"marketCap":788607087},{"date":"2023-03-24","current":-20.659679,"twenty":-33.801144,"median":-30.612951,"eighty":-27.867476,"marketCap":716518982},{"date":"2023-03-31","current":-17.719962,"twenty":-33.618064,"median":-30.576023,"eighty":-26.2038,"marketCap":614563712},{"date":"2023-04-06","current":-15.732931,"twenty":-33.565575,"median":-30.176574,"eighty":-25.70897,"marketCap":545649501},{"date":"2023-04-14","current":-16.631178,"twenty":-33.492841,"median":-29.970507,"eighty":-24.113699,"marketCap":576802501},{"date":"2023-04-21","current":-17.973502,"twenty":-33.463206,"median":-29.344076,"eighty":-23.419462,"marketCap":623356984},{"date":"2023-04-28","current":-17.210989,"twenty":-33.352032,"median":-29.090384,"eighty":-19.070054,"marketCap":596911536},{"date":"2023-05-05","current":-16.693286,"twenty":-33.350744,"median":-28.918758,"eighty":-18.073817,"marketCap":578956528},{"date":"2023-05-12","current":-12.329028,"twenty":-33.323434,"median":-28.627161,"eighty":-17.841072,"marketCap":427595344},{"date":"2023-05-19","current":-17.294264,"twenty":-33.212652,"median":-28.359496,"eighty":-17.789501,"marketCap":733155735},{"date":"2023-05-26","current":-17.057707,"twenty":-33.123305,"median":-28.101877,"eighty":-17.789501,"marketCap":723127390},{"date":"2023-06-02","current":-15.358643,"twenty":-33.120421,"median":-28.024971,"eighty":-17.719962,"marketCap":651098973},{"date":"2023-06-09","current":-15.179795,"twenty":-32.981454,"median":-27.978649,"eighty":-17.665522,"marketCap":643517035},{"date":"2023-06-16","current":-13.525443,"twenty":-32.939388,"median":-27.584891,"eighty":-17.230009,"marketCap":573384103},{"date":"2023-06-23","current":-14.352619,"twenty":-32.898926,"median":-26.292426,"eighty":-16.984823,"marketCap":608450569},{"date":"2023-06-30","current":-14.777385,"twenty":-32.852687,"median":-26.033933,"eighty":-16.443167,"marketCap":626457673},{"date":"2023-07-07","current":-14.374975,"twenty":-32.778571,"median":-25.664657,"eighty":-16.200645,"marketCap":609398311},{"date":"2023-07-14","current":-15.381,"twenty":-32.650157,"median":-24.815323,"eighty":-15.896248,"marketCap":652046716},{"date":"2023-07-20","current":-16.342312,"twenty":-32.522678,"median":-23.947525,"eighty":-15.738555,"marketCap":692799635},{"date":"2023-07-28","current":-14.889165,"twenty":-32.268091,"median":-23.449004,"eighty":-15.666005,"marketCap":631196385},{"date":"2023-08-04","current":-15.649273,"twenty":-31.980646,"median":-22.434463,"eighty":-15.664922,"marketCap":663419624},{"date":"2023-08-11","current":-12.27233,"twenty":-31.772476,"median":-20.321699,"eighty":-15.577733,"marketCap":654642902},{"date":"2023-08-18","current":-12.05734,"twenty":-31.358888,"median":-18.902086,"eighty":-15.443597,"marketCap":643174706},{"date":"2023-08-25","current":-12.361909,"twenty":-31.218563,"median":-18.499284,"eighty":-15.287104,"marketCap":659421318},{"date":"2023-08-30","current":-12.70231,"twenty":-31.152094,"median":-18.359623,"eighty":-15.152968,"marketCap":677579296},{"date":"2023-09-08","current":-13.114373,"twenty":-31.100395,"median":-18.231502,"eighty":-15.005417,"marketCap":699560007},{"date":"2023-09-15","current":-13.04271,"twenty":-31.033926,"median":-18.031385,"eighty":-14.777385,"marketCap":695737274},{"date":"2023-09-20","current":-11.833393,"twenty":-31.022847,"median":-18.002563,"eighty":-14.750557,"marketCap":631228667},{"date":"2023-09-27","current":-6.718429,"twenty":-31.011769,"median":-17.988032,"eighty":-14.670075,"marketCap":358381151},{"date":"2023-10-05","current":-7.166324,"twenty":-30.867751,"median":-17.964938,"eighty":-14.419687,"marketCap":382273228},{"date":"2023-10-13","current":-6.718429,"twenty":-30.668342,"median":-17.875755,"eighty":-14.196126,"marketCap":358381151},{"date":"2023-10-20","current":-6.055544,"twenty":-30.649879,"median":-17.782874,"eighty":-14.047454,"marketCap":323020877},{"date":"2023-10-27","current":-6.306365,"twenty":-30.649879,"median":-17.728408,"eighty":-14.012806,"marketCap":336400440},{"date":"2023-11-03","current":-6.539271,"twenty":-30.635108,"median":-17.710569,"eighty":-13.713234,"marketCap":348824320},{"date":"2023-11-10","current":-5.319172,"twenty":-30.612951,"median":-17.665522,"eighty":-13.225451,"marketCap":327799293},{"date":"2023-11-17","current":-7.025405,"twenty":-30.612951,"median":-17.36121,"eighty":-12.859969,"marketCap":432947606},{"date":"2023-11-24","current":-7.41484,"twenty":-30.59818,"median":-17.220775,"eighty":-12.627063,"marketCap":456946919},{"date":"2023-12-01","current":-7.523882,"twenty":-30.480012,"median":-17.057707,"eighty":-12.494486,"marketCap":463666727},{"date":"2023-12-08","current":-8.1314,"twenty":-30.216835,"median":-16.553813,"eighty":-12.335604,"marketCap":501105655},{"date":"2023-12-15","current":-8.115823,"twenty":-30.090944,"median":-16.431736,"eighty":-12.243664,"marketCap":500145682},{"date":"2023-12-22","current":-7.944471,"twenty":-30.007565,"median":-16.309818,"eighty":-8.996418,"marketCap":489585985},{"date":"2023-12-29","current":-8.770073,"twenty":-29.979771,"median":-16.222884,"eighty":-8.287174,"marketCap":540464528},{"date":"2024-01-05","current":-8.785651,"twenty":-29.917293,"median":-16.174641,"eighty":-8.399331,"marketCap":541424501},{"date":"2024-01-12","current":-9.112776,"twenty":-29.704533,"median":-16.005127,"eighty":-8.58626,"marketCap":561583924},{"date":"2024-01-19","current":-9.471056,"twenty":-29.440705,"median":-15.977907,"eighty":-8.629876,"marketCap":583663292},{"date":"2024-01-26","current":-10.156461,"twenty":-29.180978,"median":-15.857321,"eighty":-8.707763,"marketCap":625902083},{"date":"2024-02-02","current":-9.969533,"twenty":-29.156298,"median":-15.732931,"eighty":-8.773189,"marketCap":614382412},{"date":"2024-02-09","current":-10.109729,"twenty":-29.07732,"median":-15.682807,"eighty":-8.798113,"marketCap":623022165},{"date":"2024-02-16","current":-11.309188,"twenty":-29.025066,"median":-15.649273,"eighty":-8.900923,"marketCap":696940049},{"date":"2024-02-23","current":-11.83882,"twenty":-29.025066,"median":-15.515136,"eighty":-9.112776,"marketCap":729579115},{"date":"2024-03-01","current":-13.038279,"twenty":-28.81245,"median":-15.453657,"eighty":-9.20624,"marketCap":803496999},{"date":"2024-03-08","current":-13.941768,"twenty":-28.8035,"median":-15.381,"eighty":-9.20624,"marketCap":859175405},{"date":"2024-03-15","current":-14.019655,"twenty":-28.627161,"median":-15.258041,"eighty":-9.237395,"marketCap":863975268},{"date":"2024-03-22","current":-15.975609,"twenty":-28.534516,"median":-15.179795,"eighty":-9.252972,"marketCap":868513986},{"date":"2024-03-28","current":-17.679674,"twenty":-28.423343,"median":-15.269219,"eighty":-9.315282,"marketCap":961155477},{"date":"2024-04-05","current":-16.916395,"twenty":-28.337864,"median":-15.369822,"eighty":-9.405631,"marketCap":919659809},{"date":"2024-04-12","current":-16.401625,"twenty":-28.264358,"median":-15.43689,"eighty":-9.46171,"marketCap":891674358},{"date":"2024-04-19","current":-14.981571,"twenty":-28.131419,"median":-15.49278,"eighty":-9.483518,"marketCap":814473115},{"date":"2024-04-26","current":-14.360297,"twenty":-28.077411,"median":-15.403356,"eighty":-9.636176,"marketCap":780697571},{"date":"2024-05-03","current":-16.860498,"twenty":-28.034236,"median":-15.420123,"eighty":-9.72341,"marketCap":916620967},{"date":"2024-05-10","current":-17.157732,"twenty":-27.987913,"median":-15.505955,"eighty":-9.779488,"marketCap":852670667},{"date":"2024-05-17","current":-17.742813,"twenty":-27.978649,"median":-15.537492,"eighty":-9.809086,"marketCap":881746829},{"date":"2024-05-24","current":-17.157885,"twenty":-27.978649,"median":-15.649273,"eighty":-9.876069,"marketCap":852678252},{"date":"2024-05-31","current":-17.313866,"twenty":-27.867476,"median":-15.716341,"eighty":-9.910338,"marketCap":860429873},{"date":"2024-06-07","current":-17.177383,"twenty":-27.668279,"median":-15.746992,"eighty":-9.932147,"marketCap":853647205},{"date":"2024-06-14","current":-16.884919,"twenty":-27.543213,"median":-15.872834,"eighty":-9.957071,"marketCap":839112916},{"date":"2024-06-21","current":-15.929536,"twenty":-27.026227,"median":-15.872834,"eighty":-9.981995,"marketCap":791634241},{"date":"2024-06-28","current":-16.592455,"twenty":-26.233342,"median":-15.857321,"eighty":-10.038073,"marketCap":824578628},{"date":"2024-07-05","current":-17.742813,"twenty":-26.122559,"median":-15.901185,"eighty":-10.097267,"marketCap":881746829},{"date":"2024-07-12","current":-22.129772,"twenty":-26.004391,"median":-15.977907,"eighty":-10.112844,"marketCap":1099761155},{"date":"2024-07-19","current":-20.550467,"twenty":-25.84191,"median":-16.008119,"eighty":-10.131537,"marketCap":1021275998},{"date":"2024-07-26","current":-21.408361,"twenty":-25.598187,"median":-16.06602,"eighty":-10.234348,"marketCap":1063909910},{"date":"2024-08-02","current":-19.302621,"twenty":-25.251068,"median":-16.155521,"eighty":-10.620668,"marketCap":959263034},{"date":"2024-08-09","current":-23.520911,"twenty":-24.881793,"median":-16.206368,"eighty":-10.941562,"marketCap":1054724705},{"date":"2024-08-16","current":-28.81744,"twenty":-25.84191,"median":-16.286222,"eighty":-11.035026,"marketCap":1292231647},{"date":"2024-08-23","current":-28.017556,"twenty":-27.270827,"median":-16.393243,"eighty":-11.081758,"marketCap":1256363252},{"date":"2024-08-30","current":-28.060793,"twenty":-27.941591,"median":-16.401625,"eighty":-11.197031,"marketCap":1258302084},{"date":"2024-09-06","current":-24.558599,"twenty":-27.79336,"median":-16.442915,"eighty":-11.309188,"marketCap":1101256678},{"date":"2024-09-13","current":-28.752585,"twenty":-27.79336,"median":-16.472628,"eighty":-11.620736,"marketCap":1289323399},{"date":"2024-09-20","current":-31.930502,"twenty":-27.995938,"median":-16.576918,"eighty":-11.620736,"marketCap":1431827564},{"date":"2024-09-27","current":-30.95767,"twenty":-28.060793,"median":-16.631178,"eighty":-11.714201,"marketCap":1388203840},{"date":"2024-10-04","current":-30.67663,"twenty":-28.212122,"median":-16.751589,"eighty":-11.833393,"marketCap":1375601431},{"date":"2024-10-11","current":-31.39004,"twenty":-28.39555,"median":-16.860498,"eighty":-11.83882,"marketCap":1407592162},{"date":"2024-10-18","current":-34.567957,"twenty":-28.752585,"median":-16.884919,"eighty":-11.967761,"marketCap":1550096327},{"date":"2024-10-25","current":-31.930502,"twenty":-28.968769,"median":-17.021402,"eighty":-12.05734,"marketCap":1431827564},{"date":"2024-11-01","current":-32.989808,"twenty":-29.172776,"median":-17.10772,"eighty":-12.236498,"marketCap":1479328953},{"date":"2024-11-08","current":-36.837898,"twenty":-29.53085,"median":-17.177383,"eighty":-12.27233,"marketCap":1651885017},{"date":"2024-11-15","current":-27.728261,"twenty":-29.574087,"median":-17.203935,"eighty":-12.290246,"marketCap":1361568504},{"date":"2024-11-22","current":-27.708469,"twenty":-29.53085,"median":-17.216378,"eighty":-12.329028,"marketCap":1360596650},{"date":"2024-11-29","current":-28.717849,"twenty":-29.510269,"median":-17.294264,"eighty":-12.329028,"marketCap":1410161242},{"date":"2024-12-06","current":-27.748052,"twenty":-29.318167,"median":-17.323614,"eighty":-12.355333,"marketCap":1362540359},{"date":"2024-12-13","current":-23.552198,"twenty":-29.200708,"median":-17.377363,"eighty":-12.390575,"marketCap":1156507152},{"date":"2024-12-20","current":-22.127191,"twenty":-29.174826,"median":-17.429503,"eighty":-12.426406,"marketCap":1086533610},{"date":"2024-12-27","current":-21.355313,"twenty":-29.123341,"median":-17.460097,"eighty":-12.465821,"marketCap":1048631275},{"date":"2025-01-03","current":-22.146983,"twenty":-29.064257,"median":-17.508842,"eighty":-12.501652,"marketCap":1087505465},{"date":"2025-01-10","current":-22.245942,"twenty":-29.025066,"median":-17.556082,"eighty":-12.530317,"marketCap":1092364739},{"date":"2025-01-17","current":-24.878247,"twenty":-29.013807,"median":-17.625827,"eighty":-12.566149,"marketCap":1221621420},{"date":"2025-01-24","current":-27.866803,"twenty":-28.968769,"median":-17.665522,"eighty":-12.594815,"marketCap":1368371488},{"date":"2025-01-31","current":-25.768876,"twenty":-28.968769,"median":-17.692748,"eighty":-12.61273,"marketCap":1265354884},{"date":"2025-02-07","current":-23.591782,"twenty":-28.81744,"median":-17.719962,"eighty":-12.684394,"marketCap":1158450862},{"date":"2025-02-14","current":-23.7897,"twenty":-28.81245,"median":-17.725862,"eighty":-12.70231,"marketCap":1168169409},{"date":"2025-02-21","current":-22.245942,"twenty":-28.80529,"median":-17.742813,"eighty":-12.730975,"marketCap":1092364739},{"date":"2025-02-28","current":-20.741768,"twenty":-28.766646,"median":-17.750677,"eighty":-12.878556,"marketCap":1018503778},{"date":"2025-03-07","current":-21.474063,"twenty":-28.753554,"median":-17.783612,"eighty":-12.988431,"marketCap":1054462403},{"date":"2025-03-14","current":-23.492823,"twenty":-28.724796,"median":-17.918291,"eighty":-13.032048,"marketCap":1153591588},{"date":"2025-03-21","current":151.633005,"twenty":-28.645299,"median":-17.929848,"eighty":-12.988431,"marketCap":1212760777},{"date":"2025-03-28","current":153.227851,"twenty":-28.604711,"median":-17.78435,"eighty":-12.670061,"marketCap":1225516351},{"date":"2025-04-04","current":157.030944,"twenty":-28.551598,"median":-17.756493,"eighty":-12.515985,"marketCap":1255933491},{"date":"2025-04-11","current":172.365997,"twenty":-28.537065,"median":-17.742813,"eighty":-12.355333,"marketCap":1378583246},{"date":"2025-04-17","current":182.548472,"twenty":-28.53527,"median":-17.728408,"eighty":-12.28308,"marketCap":1460022683},{"date":"2025-04-25","current":168.930945,"twenty":-28.478265,"median":-17.719962,"eighty":-11.916185,"marketCap":1351109701},{"date":"2025-05-02","current":177.55989,"twenty":-28.413636,"median":-17.701176,"eighty":-11.620736,"marketCap":1420124003},{"date":"2025-05-09","current":165.034919,"twenty":-28.363303,"median":-17.672598,"eighty":-11.047488,"marketCap":1319949281},{"date":"2025-05-16","current":-85.348526,"twenty":-28.478265,"median":-17.679674,"eighty":-10.985179,"marketCap":1335704429},{"date":"2025-05-23","current":-91.122103,"twenty":-28.610323,"median":-17.701176,"eighty":-11.047488,"marketCap":1426060905},{"date":"2025-05-30","current":-97.209461,"twenty":-28.755493,"median":-17.719962,"eighty":-11.103567,"marketCap":1521328059},{"date":"2025-06-06","current":-84.344425,"twenty":-28.908237,"median":-17.728408,"eighty":-11.22507,"marketCap":1319990259},{"date":"2025-06-13","current":-90.369027,"twenty":-29.139819,"median":-17.742813,"eighty":-11.433807,"marketCap":1414275278},{"date":"2025-06-20","current":-99.845224,"twenty":-29.414401,"median":-17.756493,"eighty":-11.620736,"marketCap":1562577755},{"date":"2025-06-27","current":-113.463334,"twenty":-29.625971,"median":-17.78435,"eighty":-11.639429,"marketCap":1775701182},{"date":"2025-07-03","current":-103.673356,"twenty":-29.970507,"median":-17.918291,"eighty":-11.714201,"marketCap":1622488027},{"date":"2025-07-11","current":-112.835772,"twenty":-30.109473,"median":-17.96922,"eighty":-11.833393,"marketCap":1765879826},{"date":"2025-07-18","current":-115.157754,"twenty":-30.373971,"median":-18.060207,"eighty":-11.83882,"marketCap":1802218844},{"date":"2025-07-25","current":-112.459234,"twenty":-30.612951,"median":-18.156476,"eighty":-11.967761,"marketCap":1759987013},{"date":"2025-07-29","current":-115.157754,"twenty":-30.612951,"median":-18.201631,"eighty":-12.003593,"marketCap":1802218844}],"updateTime":1753949791666}}}